127 related articles for article (PubMed ID: 2952213)
1. Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer.
Parmar H; Edwards L; Phillips RH; Allen L; Lightman SL
Br J Urol; 1987 Mar; 59(3):248-54. PubMed ID: 2952213
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.
Parmar H; Phillips RH; Lightman SL; Edwards L; Allen L; Schally AV
Lancet; 1985 Nov; 2(8466):1201-5. PubMed ID: 2866289
[TBL] [Abstract][Full Text] [Related]
3. How would you like to have an orchidectomy for advanced prostatic cancer?
Parmar H; Phillips RH; Lightman SL; Edwards L
Am J Clin Oncol; 1988; 11 Suppl 2():S160-8. PubMed ID: 2977271
[TBL] [Abstract][Full Text] [Related]
4. Orchidectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer.
Williams G
Lancet; 1986 Jan; 1(8473):157. PubMed ID: 2867375
[No Abstract] [Full Text] [Related]
5. A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
De Sy WA; de Meyer JM; Casselman J; De Smet R; Renders G; Schelfhout W; De Wilde P
Acta Urol Belg; 1986; 54(2):221-9. PubMed ID: 2942015
[No Abstract] [Full Text] [Related]
6. [Use of LHRH agonists in the treatment of advanced cancer of the prostate].
Fretin J
Arch Esp Urol; 1990; 43(6):647-9. PubMed ID: 2151155
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agents.
Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
Prostate; 1986; 9(4):327-42. PubMed ID: 2947053
[TBL] [Abstract][Full Text] [Related]
8. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
[No Abstract] [Full Text] [Related]
9. [Treatment of prostatic cancers by periodic administration of a delayed-release preparation of D-Trp(6)-LHRH].
Roger M; Duchier J; Lahlou N; Schally AV
Ann Urol (Paris); 1986; 20(2):109-12. PubMed ID: 2424359
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
12. Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer.
Kahan A; Delrieu F; Amor B; Chiche R; Steg A
Lancet; 1984 Apr; 1(8383):971-2. PubMed ID: 6143912
[No Abstract] [Full Text] [Related]
13. [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases].
Steg A; Chiche R; Boccon-Gibod L; Debré B
Presse Med; 1985 Nov; 14(40):2045-8. PubMed ID: 2934695
[TBL] [Abstract][Full Text] [Related]
14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
15. Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial.
Boccardo F; Decensi A; Guarneri D; Rubagotti A; Martorana G; Giberti C; Cerruti GB; Tani F; Zanollo A; Germinale T
Am J Clin Oncol; 1988; 11 Suppl 2():S129-31. PubMed ID: 2977269
[TBL] [Abstract][Full Text] [Related]
16. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
St Arnaud R; Lachance R; Dupont A; Labrie F
J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
[TBL] [Abstract][Full Text] [Related]
17. Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
Botto H; Richard F; Mathieu F; Camey M
Prog Clin Biol Res; 1989; 303():53-60. PubMed ID: 2528740
[No Abstract] [Full Text] [Related]
18. Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
De Sy WA; De Wilde P; De Meyer JM; Casselman J; Desmet R; Renders G; Schelfhout W
Acta Urol Belg; 1988; 56(4):581-8. PubMed ID: 2974680
[No Abstract] [Full Text] [Related]
19. Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH.
Gonzalez-Barcena D; Perez-Sanchez P; Ureta-Sanchez S; Berea Dominguez H; Graef-Sanchez A; Becerril Morales M; Comaru-Schally AM; Schally AV
Prostate; 1985; 7(1):21-30. PubMed ID: 2934692
[TBL] [Abstract][Full Text] [Related]
20. Sustained impairment of pituitary and testicular function in prostatic cancer patients treated with a depot form of a GnRH agonist.
Rolandi E; Franceschini R; Giberti C; Brancadoro T; Martorana G; Barreca T
Horm Res; 1988; 30(1):22-5. PubMed ID: 2975631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
